December 16, 2019
Last Week P/L
12/: +$72 12/10: +$3,009 12/11: $0 12/12: $1,219.50 12/13: +$1,974
State of the Markets
A phase 1 deal is in the books, but not yet in the books really. There of course is the chance something wild could happen while we wait for official signatures but all signs point towards this deal being wrapped up and some serious buying into year end as well as the new year.
Stocks To Watch This Week
Bluebird Bio ($BLUE) Is a volatile biotech play that is nearing confirmation for a massive potential reversal. That reversal takes a big step forward to confirming its reversal with a move over and hold of $90 tomorrow which is where i’ll be entering. You will note I have a tight stop however. Doesn’t mean the reversal won’t happen if we get stopped out, I just will be reconsidering the enxt nearest support for a dip buy. But the trade plan is buy over $90, price target $94+ tomorrow, and if we are closing over $95 it’s a definite swing. Even with it being a bio, and offering susceptible.
Amarin Corporation PLC ($AMRN) is a Biotechnology company in the Healthcare sector. This stock sky rocketed during after-hours trading Friday evening, after raising its guidance by $100 million due to the FDA approval of their new drug, Vascepa. Management stated that they “now expect net revenue to reach $410 million to $425 million this year, up from its previous view of $380 million to $420 million, and $650 million to $700 million next year. Analysts surveyed by FactSet expected roughly $410 million this year and nearly $655 million next year.” I plan to day trade this on a dip buy at the 25.85 natural support level.
Want more picks like this? Visit our website for daily stock watch-lists!